FORA Capital’s Replimune Group REPL Stock Holding History

FORA Capital’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,034	Closed	-$40K	–	760
2021 Q2	$40K	Buy	+1,034	New	+$35.4K	0.01%	748

Other funds holding REPL

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

FORA Capital's REPL Position: Q3 2021 in Review

FORA Capital sold out of Replimune Group (REPL) in Q3 2021, closing a stake of 1,034 shares — an estimated $40K sold.

FORA Capital first reported a position in REPL in Q2 2021 and held it in 1 quarter. The position peaked at $40K in Q2 2021. 101 funds tracked by Wall St. Rank hold REPL as of Q3 2021.

FORA Capital reported no remaining Replimune Group position as of Q3 2021 after selling out during the quarter.
FORA Capital sold 1,034 Replimune Group shares in Q3 2021, an estimated $40K.
FORA Capital first reported a position in Replimune Group in Q2 2021 and held it in 1 quarter.
FORA Capital's Replimune Group position peaked at $40K in Q2 2021.
101 funds tracked by Wall St. Rank held Replimune Group as of Q3 2021.

Based on FORA Capital's 13F filing for Q3 2021, filed 15 Nov 2021.